Blocking STAT3 signaling augments MEK/ERK inhibitor efficacy in esophageal squamous cell carcinoma

Esophageal squamous cell carcinoma (ESCC) is one of the world’s leading causes of death, and its primary clinical therapy relies on surgical resection, chemotherapy, radiotherapy, and chemoradiotherapy. Although the genomic features and clinical significance of ESCC have been identified, the outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zhen-Yuan, Chu, Man-Yu, Lin, Wan, Zheng, Ya-Qi, Xu, Xiu-E, Chen, Yang, Liao, Lian-Di, Wu, Zhi-Yong, Wang, Shao-Hong, Li, En-Min, Xu, Li-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132929/
https://www.ncbi.nlm.nih.gov/pubmed/35614034
http://dx.doi.org/10.1038/s41419-022-04941-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132929/
https://www.ncbi.nlm.nih.gov/pubmed/35614034
http://dx.doi.org/10.1038/s41419-022-04941-3

Ejemplares similares